市場調查報告書
商品編碼
1625209
2030 年異丙醇市場預測:按類型、形狀、分銷管道、應用、最終用戶和地區進行的全球分析Isopropyl Alcohol Market Forecasts to 2030 - Global Analysis By Type, Form, Distribution Channel, Application, End User and By Geography |
根據Stratistics MRC的數據,2024年全球異丙醇市場規模為33億美元,預計在預測期內將以9.8%的複合年成長率成長,並在2030年達到59億美元。
異丙醇,也稱為異丙醇或外用酒精,是一種無色、易燃液體,具有強烈氣味。由於其能夠殺死細菌、病毒和真菌,通常用作消毒劑、防腐劑和溶劑。異丙醇廣泛用於清洗劑、乾洗手劑和醫療應用中,用於消毒表面和設備。它也用於化妝品和個人保健產品。其化學式為C3H8O,是工業及家庭用途的重要化合物。
據Astra Zeneca稱,美國在藥品銷售方面佔據主導地位,佔全球藥品銷售量的 45% 以上和全球產量的 22%。 2024 年美國藥品銷售額預計將達到 6,330 億美元。
對消毒劑和消毒劑的需求增加
由於異丙醇(IPA)廣泛用於消毒劑和消毒劑,其需求量顯著增加。它已成為清洗產品的重要成分,特別是在大流行之後,隨著世界變得更加注重衛生和感染控制。由於其能夠有效殺死細菌、病毒和其他病原體,因此廣泛應用於醫療保健、製造和家用產品等多種行業。消毒劑和消毒劑需求的快速成長預計將持續下去,推動市場進一步走高。
嚴格的法規環境
市場上嚴格的法規環境可能會導致合規成本增加、產品核可延遲以及創新受到限制。公司在滿足嚴格的安全和環境標準方面可能面臨挑戰,這可能會阻礙市場進入和擴張。此外,過度監管可能會導致供應鏈中斷,減少異丙醇的可得性,並對依賴異丙醇進行製造和滅菌的行業產生負面影響。
擴大醫藥產業
製藥業的擴張是市場成長的主要動力。 IPA 廣泛用於藥品製造中,清洗設備、消毒表面以及作為藥物配方的溶劑。隨著全球製藥業的成長,特別是疫苗、藥品和醫療設備產量的增加,對IPA的需求不斷增加。 IPA 作為消毒劑和溶劑的有效性在維持製藥設施的清潔和品管方面發揮著重要作用。
原物料價格不穩定
市場上原物料價格的波動會極大地影響生產成本並導致消費者的價格不穩定。由於丙烯等原料成本的波動影響整體定價策略,製造商可能難以維持利潤率。這種不可預測性還可能導致供不應求和庫存過剩,擾亂生產計劃,並使企業難以進行長期規劃。
COVID-19大流行顯著增加了對異丙醇的需求,異丙醇廣泛用於消毒劑和消毒劑。需求激增導致供不應求和價格上漲。然而,勞動力短缺和原料供應鏈中斷等生產挑戰影響了製造商滿足需求的能力。儘管大流行後市場正在趨於穩定,但對供應鏈和價格波動的揮之不去的影響仍然令人擔憂。
預計液體部分在預測期內將是最大的
由於液體領域在清洗、消毒和工業應用方面的高效性,預計在預測期內將佔據最大的市場佔有率。液體異丙醇因其易於使用、快速蒸發和多功能性而成為醫療保健、製藥和製造等多種行業的首選。異丙醇有多種濃度可供選擇,其中 70% 和 99% 的溶液最常用於消毒和清洗應用。
預計醫療保健產業在預測期內複合年成長率最高
預計醫療保健產業在預測期內的複合年成長率最高。廣泛用於醫療設備消毒、手部消毒、注射和手術前清洗皮膚。 70%的濃度對於殺死細菌、病毒和真菌特別有效。其快速蒸發和強大的防腐性能使其在醫院和診所等醫療機構中至關重要,可確保無菌環境並降低污染風險。
預計北美地區在預測期內將佔據最大的市場佔有率。消毒劑使用的增加,特別是在 COVID-19 大流行期間,顯著促進了市場成長。該地區的主要企業專注於生產高品質異丙醇,以滿足嚴格的監管標準。此外,對消毒劑和清洗劑的需求不斷成長,進一步提振了市場,該地區在全球消費量中保持主導地位。
預計亞太地區在預測期內將實現最高成長率。異丙醇在醫療保健領域的需求不斷增加,因為它被用作消毒劑和防腐劑,特別是在大流行期間和之後。在印度、中國和日本等國家尤其如此。此外,印度、中國和東南亞國家等國家的快速工業化正在推動汽車、建築和紡織等製造過程中使用異丙醇的行業對異丙醇的需求。
According to Stratistics MRC, the Global Isopropyl Alcohol Market is accounted for $3.3 billion in 2024 and is expected to reach $5.9 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Isopropyl alcohol, also known as isopropanol or rubbing alcohol, is a colorless, flammable liquid with a strong odor. It is commonly used as a disinfectant, antiseptic, and solvent due to its ability to kill bacteria, viruses, and fungi. Isopropyl alcohol is widely employed in cleaning products, hand sanitizers, and medical applications for sterilizing surfaces and equipment. It can also be used in cosmetics and personal care products. With a chemical formula of C3H8O, it is an important compound in both industrial and household settings.
According to AstraZeneca, the United States dominates pharmaceutical sales with a share of over 45% of global pharmaceutical sales and 22% of global production. The projected pharmaceutical sales for the United States in 2024 are expected to be USD 633 billion.
Increasing demand for disinfectants and sanitizers
The demand for Isopropyl Alcohol (IPA) has experienced significant growth due to its widespread use in disinfectants and sanitizers. As global awareness of hygiene and infection control rises, especially post-pandemic, it has become a crucial ingredient in cleaning products. Its effectiveness in killing bacteria, viruses, and other pathogens drives its use across various industries, including healthcare, manufacturing, and household products. This surge in demand for sanitizers and disinfectants is expected to continue, further boosting the market.
Strict regulatory environment
A strict regulatory environment in the market can lead to increased compliance costs, delays in product approvals, and limited innovation. Companies may face challenges in meeting stringent safety and environmental standards, which can hinder market entry and expansion. Additionally, excessive regulations can create supply chain disruptions and reduce the availability of isopropyl alcohol, negatively impacting industries that rely on it for manufacturing and sanitization purposes.
Expanding pharmaceutical industry
The expanding pharmaceutical industry is a key driver of growth in the market. IPA is widely used in pharmaceutical manufacturing for cleaning equipment, sterilizing surfaces, and as a solvent in drug formulations. As the global pharmaceutical sector grows, particularly with the rise in production of vaccines, medicines, and medical devices, the demand for IPA continues to increase. Its effectiveness as a disinfectant and solvent ensures its vital role in maintaining cleanliness and quality control in pharmaceutical facilities.
Volatile raw material prices
Volatile raw material prices in the market can significantly impact production costs, leading to price instability for consumers. Manufacturers may struggle to maintain profit margins, as fluctuating costs of feedstocks like propylene affect overall pricing strategies. This unpredictability can also result in supply shortages or overstocking, disrupting production schedules and making it difficult for companies to plan long-term, which may hinder market growth and investor confidence.
The COVID-19 pandemic significantly boosted the demand for isopropyl alcohol due to its widespread use in disinfectants and sanitizers. This surge in demand led to supply shortages and increased prices. However, production challenges, such as labor shortages and disruptions in raw material supply chains, affected manufacturers' ability to meet demand. Post-pandemic, the market is stabilizing, but lingering effects on supply chains and pricing volatility remain an ongoing concern.
The liquid segment is expected to be the largest during the forecast period
The liquid segment is expected to account for the largest market share during the projection period as it is highly effective for cleaning, disinfecting, and industrial applications. Liquid isopropyl alcohol is preferred due to its ease of use, fast evaporation, and versatility across various sectors, including healthcare, pharmaceuticals, and manufacturing. It is available in different concentrations, with 70% and 99% solutions being the most widely used for sanitization and cleaning purposes.
The healthcare segment is expected to have the highest CAGR during the forecast period
The healthcare segment is expected to have the highest CAGR during the extrapolated period. It is widely used for disinfecting medical equipment, sanitizing hands, and cleaning skin before injections or surgeries. The 70% concentration is especially effective in killing bacteria, viruses, and fungi. Its rapid evaporation and strong antiseptic properties make it indispensable in hospitals, clinics, and other healthcare facilities, ensuring a sterile environment and reducing the risk of contamination.
North America region is projected to account for the largest market share during the forecast period. The increasing use of sanitizers, especially during the COVID-19 pandemic, significantly boosted market growth. Key players in the region focus on manufacturing high-quality isopropyl alcohol to meet stringent regulatory standards. Additionally, the growing demand for disinfectants and cleaning products further propels the market, with the region maintaining a dominant share in global consumption.
Asia Pacific is expected to register the highest growth rate over the forecast period. The use of Isopropyl Alcohol as a disinfectant and antiseptic, especially during and post-pandemic, has led to increased demand in the healthcare sector. This is particularly true in countries like India, China, and Japan. Additionally, the rapid industrialization in countries like India, China, and Southeast Asian nations drives demand for IPA in sectors like automotive, construction, and textiles, where it is used in manufacturing processes.
Key players in the market
Some of the key players in Isopropyl Alcohol market include Mitsubishi Chemical Corporation, Huntsman Corporation, SK Innovation, Covestro AG, Eastman Chemical Company, Nippon Shokubai Co., Ltd., Reliance Industries Limited, Mosaic Chemical Co. Ltd., Merck Group, Solvay S.A., ExxonMobil Corporation, Royal Dutch Shell Plc, Dow Inc., LG Chem Ltd., BASF SE and SABIC.
In November 2024, Solvay has reached an agreement to license its advanced hydrogen peroxide technology to North Huajin for use in its Panjin plant in Liaoning Province, China, which can produce 300,000 tonnes of propylene oxide per year and is scheduled to start production in 2026.
In October 2024, Covestro AG has entered into a pivotal Investment Agreement with ADNOC and its subsidiary, ADNOC International Germany Holding AG. As part of the deal, ADNOC International has launched a public takeover offer, proposing to acquire all outstanding Covestro shares at a price of €62.00 (US$68.75) per share, a premium of 54% over Covestro's unaffected share price before media coverage of the potential transaction.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.